Logo Asphalion

In2sight | In-vivo optical imaging

February 24, 2022

Asphalion is the regulatory partner throughout the EU-funded H2020 project In2sight.

The goal of the project is to foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials, a technology that will recast our thinking of biomaterial validation, allowing unprecedented quantitative and longitudinal analyses of the host inflammatory response to the implant.

In2Sight is now on Twitter and we would like to invite you to follow the In2sight account to be up-to-date on the newest developments: @in2_sight

Additionally, you can also learn more on the project´s website:


For further information, you can contact us at: info@asphalion.com


Search News & Events

  • Filter by category


Related news and events


‘RBDCOV Talks’ brings vaccine clinical research closer to the general audience through a podcast series with 10 scientists, clinicians, specialists and community advocates who are partners in the project.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting